125742 45 02 09 2022 Letter Filing Notificatio

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 12 15 Documents

3

Document text

&21&855(1&( 3$*(
7KLV SDJH PXVW EH XSORDGHG WKURXJK &%(5 &RQQHFW 'R 127 VHQG W KLV SDJH WR WKH
DSSOLFDQW 'R 127 SRVW WKLV SDJH WR WKH %LRORJLFDO $SSURYDOV Z HEVLWH
$SSOLFDWLRQ  671 %/ 
&RPPXQLFDWLRQ 1DPH )LOLQJ 1RWLILFDWLRQ
&RPPXQLFDWLRQ ,' /75%/6),/(
,QVWUXFWLRQV IRU HQWHULQJ FRPPXQLFDWLRQ LQWR WKH DSSURSULDWH UH JXODWRU\ V\VWHP
/HWWHU 7\SH
x)LOLQJ 1RWLILFDWLRQ )/
x1R 'HILFLHQFLHV ,GHQWLILHG 1',
0LOHVWRQH 6FUHHQ 'DWD &KHFN
&RQILUP ³)LOLQJ $FWLRQ´ &ORVH 'DWH
'UDIWHG E\ 0LNH 6PLWK 
5HYLHZ +LVWRU\ FRQFXUUHQFH 
5 1DLN  . 5DYHQHOO 
0 6PLWK  . 3UXW]PDQ 
/ *RWWVFKDON  $ +RUQDWNR0XQR] 
( 6XWNRZVNL 6 :ROOHUVKLHP  ' 7KRPSVRQ ; :DQJ  ' )LQN 
7 )LQQ  . )DUL]R 
' 'LFNHUVRQ 
&RQFXUUHQFH
&RQVXPHU 6DIHW\ 2IILFHU 2955'953$ 'DYLG 'LFNHUVRQ 
FF&%(5 (OHFWURQLF 5HSRVLWRU\
2IILFH 30530& &RRUGLQDWRU +HOHQ *HPLJQDQL&%(5 30530& /LDLVRQ >&%(530530&/LDLVRQ#IGDKKVJRY@35($ &RRUGLQDWRU $GULHQQH +RUQDWNR0XQR]
(1' 2) &21&855(1&( 3$*(
7KH OHWWHU EHJLQV RQ WKH QH[W SDJH
FDA-CBER-2022-5812-0500339
86 )RRG 	 'UXJ$GPLQLVWUDWLRQ
 1HZ +DPSVKLUH$YHQXH
6LOYHU 6SULQJ 0' 
ZZZIGDJRY
2XU 671 %/  ),/,1* 127,),&$7,21
)HEUXDU\  
%LR17HFK 0DQXIDFWXULQJ *PE+
$WWHQWLRQ .DWKOHHQ &ROOLQV 063IL]HU ,QF $UFROD 5RDG&ROOHJHYLOOH 3$ 
'HDU 0V &ROOLQV3OHDVH UHIHU WR \RXU VXSSOHPHQW WR \RXU %LRORJLFV /LFHQVH $SSOLF DWLRQ %/$ VXEPLWWHG
DQG UHFHLYHG RQ 'HFHPEHU   XQGHU VHFWLRQ D RI WKH 3XEO LF +HDOWK 6HUYLFH
$FW 3+6 $FW IRU &29,' 9DFFLQH P51$ &20,51$7<:H DOVR UHIHU WR \RXU DPHQGPHQW VXEPLWWHG DQG UHFHLYHG RQ )HEUXDU\  
:H KDYH FRPSOHWHG RXU ILOLQJ UHYLHZ DQG KDYH GHWHUPLQHG WKDW \RX U VXSSOHPHQW LV
VXIILFLHQWO\ FRPSOHWH WR SHUPLW D VXEVWDQWLYH UHYLHZ 8QGHU  & )5 D ZH KDYH
ILOHG \RXU VXSSOHPHQW WRGD\ 7KH UHYLHZ FODVVLILFDWLRQ IRU WKLV V XSSOHPHQW LV 3ULRULW\
WKH UHYLHZ JRDO GDWH LV -XQH   7KLV DFNQRZOHGJPHQW RI ILO LQJ GRHV QRW PHDQ
WKDW WKLV VXSSOHPHQW KDV EHHQ DSSURYHG QRU GRHV LW UHSUHVHQW DQ \ HYDOXDWLRQ RI WKH
DGHTXDF\ RI WKH GDWD VXEPLWWHG:H DUH UHYLHZLQJ \RXU VXSSOHPHQW DFFRUGLQJ WR WKH SURFHVVHV GHVF ULEHG LQ WKH
JXLGDQFH IRU UHYLHZ VWDII DQG LQGXVWU\ Good Review Management Principles and 
Practices for PDUFA Products KWWSVZZZIGDJRYUHJXODWRU\LQIRUPDWLRQVHDUFKIGD
JXLGDQFHGRFXPHQWVJRRGUHYLHZPDQDJHPHQWSULQFLSOHVDQGSUDFWL FHVQHZGUXJ
DSSOLFDWLRQVDQGELRORJLFVOLFHQVH  7KHUHIRUH ZH KDYH HVWDEOLVKHG LQWHUQDO UHYLHZ
WLPHOLQHV DV GHVFULEHG LQ WKH JXLGDQFH ZKLFK LQFOXGHV WKH WLPH IUDPHV IRU )'$ LQWHUQDO
PLOHVWRQH PHHWLQJV HJ ILOLQJ SODQQLQJ PLGF\FOH WHDP DQG ZUDSXS PHHWLQJV
3OHDVH EH DZDUH WKDW WKH WLPHOLQHV GHVFULEHG LQ WKH JXLGDQFH DUH IOH[LEOH DQG VXEMHFW WR
FKDQJH EDVHG RQ ZRUNORDG DQG RWKHU SRWHQWLDO UHYLHZ LVVXHV HJ  VXEPLVVLRQ RI
DPHQGPHQWV :H ZLOO LQIRUP \RX RI DQ\ QHFHVVDU\ LQIRUPDWLRQ UHTXHVWV RU VWDWXV
XSGDWHV IROORZLQJ WKH PLOHVWRQH PHHWLQJV RU DW RWKHU WLPHV DV QHHGHG GXULQJ WKH
SURFHVV ,I PDMRU GHILFLHQFLHV DUH QRW LGHQWLILHG GXULQJ WKH U HYLHZ ZH SODQ WR
FRPPXQLFDWH SURSRVHG ODEHOLQJ DQG LI QHFHVVDU\ DQ\ SRVWPDUNHW LQJ
UHTXLUHPHQWFRPPLWPHQW UHTXHVWV E\ 0D\  
:H DUH QRW FXUUHQWO\ SODQQLQJ WR KROG DQ DGYLVRU\ FRPPLWWHH PHHWLQJ WR GLVFXVV WKLV
VXSSOHPHQW
$W WKLV WLPH ZH KDYH QRW LGHQWLILHG DQ\ SRWHQWLDO UHYLHZ LVVXH V 2XU ILOLQJ UHYLHZ LV RQO\
D SUHOLPLQDU\ UHYLHZ DQG GHILFLHQFLHV PD\ EH LGHQWLILHG GXULQJ VXEVWDQWLYH UHYLHZ RI
\RXU VXSSOHPHQW )ROORZLQJ D UHYLHZ RI WKH VXSSOHPHQW ZH VKDOO DGYLVH \RX LQ ZULWLQJ
RI DQ\ DFWLRQ ZH KDYH WDNHQ DQG UHTXHVW DGGLWLRQDO LQIRUPDWLRQ LI QHHGHG
FDA-CBER-2022-5812-0500340
3DJH  ± 671 %/  ± .DWKOHHQ &ROOLQV
5(48,5(' 3(',$75,& $66(660(176
8QGHU WKH 3HGLDWULF 5HVHDUFK (TXLW\ $FW 35($  86& F  DOO VXSSOHPHQWV IRU
QHZ DFWLYH LQJUHGLHQWV QHZ LQGLFDWLRQV QHZ GRVDJH IRUPV QHZ GRVLQJ UHJLPHQV RU
QHZ URXWHV RI DGPLQLVWUDWLRQ DUH UHTXLUHG WR FRQWDLQ DQ DVVHVVPHQW RI WKH VDIHW\ DQG
HIIHFWLYHQHVV RI WKH SURGXFW IRU WKH FODLPHG LQGLFDWLRQ LQ SHGL DWULF SDWLHQWV XQOHVV WKLV
UHTXLUHPHQW LV ZDLYHG GHIHUUHG RU LQDSSOLFDEOH
:H DFNQRZOHGJH \RX KDYH DGGUHVVHG 35($ IRU WKLV DSSOLFDWLRQ,I \RX KDYH DQ\ TXHVWLRQV SOHDVH FRQWDFW WKH 5HJXODWRU\ 3URMHFW 0DQDJHUV
&$37 0LNH 6PLWK 3K' HPDLO 0LFKDHO6PLWK#IGDKKVJRY  DQG
/DXUD *RWWVFKDON 3K' HPDLO /DXUD*RWWVFKDON#IGDKKVJRY  DW 
6LQFHUHO\
/RULV ' 0F9LWWLH 3K'
'HSXW\ 'LUHFWRU  5HJXODWRU\'LYLVLRQ RI 9DFFLQHV DQG
5HODWHG 3URGXFWV $SSOLFDWLRQV
2IILFH RI 9DFFLQHV
5HVHDUFK DQG 5HYLHZ
&HQWHU IRU %LRORJLFV
(YDOXDWLRQ DQG 5HVHDUFKLoris D. 
Mcvittie -SDigitally signed by Loris D. Mcvittie -S DN: c=US, o=U.S. Government, ou=HHS, ou=FDA, ou=People, 0.9.2342.19200300.100.1.1=1300064781, cn=Loris D. Mcvittie -S Date: 2022.02.09 17:00:08 -05'00'
FDA-CBER-2022-5812-0500341